Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionPreservative-free, trivalent inactivated influenza vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsTreat influenza in children aged 6 to 35 months; Vaccinate against influenza A and B virus in subjects 6 months and older; Vaccinate against influenza virus in adults >=65 years of age; Vaccinate against influenza virus in children 6 to 35 months of age
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today